Market Place
Sourcing Support
Aclaris Therapeutics Announces Global License Agreement with Biosion
18 Nov 2024 //
GLOBENEWSWIRE
Biosion Announces Global License with Aclaris for Immunology Assets
18 Nov 2024 //
PR NEWSWIRE
Biosion to Present Three Posters at the 2024 AACR Meeting
21 Mar 2024 //
PR NEWSWIRE
OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 of OBI-992
08 Jan 2024 //
PR NEWSWIRE
Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B
31 Jul 2023 //
PR NEWSWIRE
Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President
05 Jul 2023 //
PR NEWSWIRE
Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis
04 Apr 2023 //
PR NEWSWIRE
Biosion bispecific antibody therapies to be featured at AACR meeting 2023
22 Mar 2023 //
PR NEWSWIRE
Biosion Announces Collaboration with ImmunoGen to Create Antibody-Drug Conjugate
13 Dec 2022 //
PRNEWSWIRE
Biosion Appoints Steven Knapp as Chief Regulatory & Quality Officer
22 Aug 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.